Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS) Financial Statements


Emergent Biosolutions Financial Overview

Emergent Biosolutions's market cap is currently ―. The company's EPS TTM is $-11.02; its P/E ratio is -1.10; Emergent Biosolutions is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $-1.14. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 269.90M$ 270.50M$ 335.20M$ 163.30M$ -366.80M
Gross Profit$ 84.80M$ 93.70M$ 144.60M$ 8.20M$ 111.10M
EBIT$ -32.80M$ -246.20M$ -221.60M$ -143.20M$ -58.40M
EBITDA$ -3.20M$ -212.50M$ -179.80M$ -107.60M$ -40.50M
Net Income Common Stockholders$ -49.50M$ -263.40M$ -261.30M$ -183.00M$ -88.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 111.70M$ 87.80M$ 88.60M$ 430.20M$ 642.60M
Total Assets$ 1.82B$ 1.89B$ 2.18B$ 2.95B$ 3.17B
Total Debt$ 860.20M$ 861.80M$ 903.20M$ 1.40B$ 1.41B
Net Debt$ 748.50M$ 774.00M$ 814.60M$ 968.20M$ 763.20M
Total Liabilities$ 1.17B$ 1.20B$ 1.22B$ 1.75B$ 1.78B
Stockholders Equity$ 649.30M$ 697.20M$ 956.30M$ 1.20B$ 1.38B
Cash Flow-
Free Cash Flow$ 20.70M$ 47.40M$ -127.30M$ -200.60M-
Operating Cash Flow$ 32.10M$ 60.00M$ -114.80M$ -185.50M-
Investing Cash Flow$ -11.40M$ -18.90M$ 258.10M$ -13.60M-
Financing Cash Flow$ 4.70M$ -43.00M$ -486.90M$ -10.50M-
Currency in USD

Emergent Biosolutions Earnings and Revenue History

Emergent Biosolutions Debt to Assets

Emergent Biosolutions Cash Flow

Emergent Biosolutions Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis